hydrocortisone acetate has been researched along with Eczema, Atopic in 12 studies
hydrocortisone acetate: RN given refers to cpd without isomeric designation
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ceramide-containing lotion or cream containing 1% pramoxine provides both rapid and long-lasting relief of itching following a single application in atopic patients with or without active flare." | 5.24 | Anti-Pruritic Efficacy of Itch Relief Lotion and Cream in Patients With Atopic History: Comparison With Hydrocortisone Cream. ( Barkovic, S; Zirwas, MJ, 2017) |
| " The secondary outcome measurements included the following: survey questionnaires of gastrointestinal disorder, amount and frequency of ointment application for AD, dermatology quality of life index, and safety evaluation (diagnostic test, adverse reaction, and vital sign monitoring)." | 3.01 | Efficacy and safety of Soshiho-tang in atopic dermatitis patients with gastrointestinal disorders: A double-blinded, randomized, and placebo-controlled clinical trial. ( Jo, EH; Jung, JY; Kang, SJ; Lee, JH; Park, MC; Shim, YH; Yang, GJ, 2021) |
| "Atopic dermatitis is familial disease, often coexists with other atopic diseases with multiple risk factors associated with atopic eczema." | 2.80 | Topical Tacrolimus versus Hydrocortisone on Atopic Dermatitis in Paediatric Patients: A Randomized Controlled Trial. ( Banu, LA; Basher, MS; Kabir, S; Kamal, M; Nandi, AK; Rahman, MF, 2015) |
| "Observation of recurrence rate after remission was recorded." | 2.79 | Comparative trial of moisturizer containing spent grain wax, Butyrospermum parkii extract, Argania spinosa kernel oil vs. 1% hydrocortisone cream in the treatment of childhood atopic dermatitis. ( Jirabundansuk, P; Ophaswongse, S; Udompataikul, M, 2014) |
| "This study was conducted to compare the efficacy of hydrocortisone cream, combined with mupirocin or alone with emmolient ointment for the treatment of mild to moderate AD in infants between six months and two years of age." | 2.77 | Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age - a randomized double blind pilot trial. ( Canpolat, F; Erkoçoğlu, M; Kandi, B; Kocabaş, CN; Tezer, H, 2012) |
| "Tacrolimus was superior for all efficacy scores at month 6, and in the head and neck area at month 12." | 2.75 | One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: A randomized, double-blind, comparative trial. ( Mandelin, J; Reitamo, S; Remitz, A; Virtanen, H, 2010) |
| "Topical corticosteroids are the usual treatment for atopic dermatitis (AD) in children but can have side-effects." | 2.71 | 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. ( Bos, JD; Bruijnzeel-Koomen, C; Cambazard, F; Dobozy, A; Harper, J; Moss, C; Palatsi, R; Reitamo, S; Smith, C; Valk, P, 2004) |
| " Transient skin burning was the only adverse event to show a higher incidence in the tacrolimus treatment groups than in the hydrocortisone acetate group (P <." | 2.70 | Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. ( Cambazard, F; de Prost, Y; Gratton, D; Harper, J; Ho, V; Jünger, M; Kalimo, K; Reitamo, S; Rustin, M; Ruzicka, T; Sauder, D; Sharpe, G; Smith, C; Taïeb, A; Van Leent, EJ, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Salava, A | 1 |
| Perälä, M | 1 |
| Juppo, M | 1 |
| Pelkonen, AS | 1 |
| Mäkelä, MJ | 1 |
| Remitz, A | 2 |
| Lee, JH | 1 |
| Jo, EH | 1 |
| Jung, JY | 1 |
| Kang, SJ | 1 |
| Yang, GJ | 1 |
| Shim, YH | 1 |
| Park, MC | 1 |
| Jirabundansuk, P | 1 |
| Ophaswongse, S | 1 |
| Udompataikul, M | 1 |
| Rahman, MF | 1 |
| Nandi, AK | 1 |
| Kabir, S | 1 |
| Kamal, M | 1 |
| Basher, MS | 1 |
| Banu, LA | 1 |
| Zirwas, MJ | 1 |
| Barkovic, S | 1 |
| Mandelin, J | 1 |
| Virtanen, H | 1 |
| Reitamo, S | 4 |
| Canpolat, F | 1 |
| Erkoçoğlu, M | 1 |
| Tezer, H | 1 |
| Kocabaş, CN | 1 |
| Kandi, B | 1 |
| FEHER, PJ | 1 |
| GRAHAM, A | 1 |
| KALZ, F | 1 |
| Harper, J | 2 |
| Bos, JD | 2 |
| Cambazard, F | 3 |
| Bruijnzeel-Koomen, C | 1 |
| Valk, P | 1 |
| Smith, C | 2 |
| Moss, C | 1 |
| Dobozy, A | 1 |
| Palatsi, R | 1 |
| Ortonne, JP | 1 |
| Sand, C | 1 |
| Bieber, T | 1 |
| Fölster-Holst, R | 1 |
| Vena, G | 1 |
| Fabbri, P | 1 |
| Groenhoej Larsen, C | 1 |
| Giannetti, A | 1 |
| Laria, G | 1 |
| Seidenari, S | 1 |
| Van Leent, EJ | 1 |
| Ho, V | 1 |
| Ruzicka, T | 1 |
| Kalimo, K | 1 |
| Rustin, M | 1 |
| Taïeb, A | 1 |
| Gratton, D | 1 |
| Sauder, D | 1 |
| Sharpe, G | 1 |
| Jünger, M | 1 |
| de Prost, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "A Double-Blind Randomized Placebo-Controlled Trial to Evaluate the Efficacy of the Атопик Soothing Cream in Children With Mild to Moderate Atopic Dermatitis"[NCT02716181] | 74 participants (Actual) | Interventional | 2016-12-29 | Completed | |||
| Comparison of the Efficacy and Safety of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® (Tacrolimus 0.1%) Ointment in Treating Atopic Dermatitis: A Randomized, Evaluator-blind, Crossover, Active-Controlled Trial[NCT03614221] | Phase 2 | 22 participants (Actual) | Interventional | 2019-06-03 | Completed | ||
| Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B[NCT05618730] | Phase 1 | 20 participants (Anticipated) | Interventional | 2022-09-29 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 trials available for hydrocortisone acetate and Eczema, Atopic
| Article | Year |
|---|---|
Efficacy and safety of Soshiho-tang in atopic dermatitis patients with gastrointestinal disorders: A double-blinded, randomized, and placebo-controlled clinical trial.
Topics: Administration, Oral; Administration, Topical; Adolescent; Child; Child, Preschool; Correlation of D | 2021 |
Comparative trial of moisturizer containing spent grain wax, Butyrospermum parkii extract, Argania spinosa kernel oil vs. 1% hydrocortisone cream in the treatment of childhood atopic dermatitis.
Topics: Administration, Cutaneous; Child; Child, Preschool; Dermatitis, Atopic; Edible Grain; Female; Humans | 2014 |
Topical Tacrolimus versus Hydrocortisone on Atopic Dermatitis in Paediatric Patients: A Randomized Controlled Trial.
Topics: Administration, Cutaneous; Child; Child, Preschool; Dermatitis, Atopic; Double-Blind Method; Female; | 2015 |
Anti-Pruritic Efficacy of Itch Relief Lotion and Cream in Patients With Atopic History: Comparison With Hydrocortisone Cream.
Topics: Administration, Cutaneous; Adult; Antipruritics; Ceramides; Dermatitis, Atopic; Double-Blind Method; | 2017 |
One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: A randomized, double-blind, comparative trial.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Butyrates; Dermat | 2010 |
Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age - a randomized double blind pilot trial.
Topics: Administration, Cutaneous; Anti-Bacterial Agents; Anti-Inflammatory Agents; Dermatitis, Atopic; Doub | 2012 |
0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
Topics: Administration, Topical; Adolescent; Anti-Inflammatory Agents; Burns, Chemical; Child; Child, Presch | 2004 |
A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Topics: Adult; Chi-Square Distribution; Dermatitis, Atopic; Dermatitis, Irritant; Double-Blind Method; Drug | 2005 |
A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Topics: Adult; Chi-Square Distribution; Dermatitis, Atopic; Dermatitis, Irritant; Double-Blind Method; Drug | 2005 |
A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Topics: Adult; Chi-Square Distribution; Dermatitis, Atopic; Dermatitis, Irritant; Double-Blind Method; Drug | 2005 |
A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Topics: Adult; Chi-Square Distribution; Dermatitis, Atopic; Dermatitis, Irritant; Double-Blind Method; Drug | 2005 |
[Hydrocortisone-17-butyrate (0.1 percent) versus hydrocortisone acetate (1 percent) in atopic dermatitis. Controlled double-blind study of 20 children].
Topics: Administration, Topical; Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Clinical Tri | 1981 |
Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis.
Topics: Administration, Topical; Adolescent; Child; Child, Preschool; Dermatitis, Atopic; Double-Blind Metho | 2002 |
2 other studies available for hydrocortisone acetate and Eczema, Atopic
| Article | Year |
|---|---|
Effective treatment of atopic dermatitis in small children significantly improves the quality of life of patients and their families.
Topics: Administration, Topical; Dermatitis, Atopic; Dermatologic Agents; Family; Female; Follow-Up Studies; | 2021 |
Topical application of flurandrenolone in the treatment of atopic dermatitis.
Topics: Adrenal Cortex Hormones; Dermatitis, Atopic; Eczema; Flurandrenolone; Humans; Hydrocortisone; Male | 1963 |